There was a significant decline in deaths from clostridioides difficile infections (CDI) among American individuals aged 35 years and above between 2011 and 2020, according to a May study published in ...

Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced that it has entered into an asset purchase agreement with Matrivax ...

Another patient linked to a C. difficile outbreak in Ontario's Niagara Region has died, bringing the total number of deaths in recent weeks to 16. The deaths have been reported at three hospitals in ...

In a phase-one human clinical trial, a pharmacist researcher has demonstrated that a new antibiotic, called Omadacycline, may be a promising tool in combating the superbug known as C diff which causes ...

Hospital-acquired infections cost the U.S. healthcare system billions annually. As CMS penalties grow and margins hover near ...

A spokesperson for the NHS Shropshire, Telford and Wrekin Integrated Care Board (ICB) said this week that "no decision has ...

Leapfrog released its 2026 spring hospital safety grades for Oklahoma. See how your local hospitals performed.

Cape Fear Valley Medical Center improved its Leapfrog patient safety grade to a B after years of C ratings, part of a broader ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q1 2026 Earnings Call Transcript May 12, 2026 Acurx Pharmaceuticals, Inc. misses ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing ...